Bookmark

Add to MyYahoo RSS

Smith and Nephew News

News on Smith and Nephew (Ticker: SNN) continually updated from thousands of sources around the net.

Sunday | Bloomberg

Perrigo, Actelion Tax Targets Abroad for U.S. Drugmakers

Drugmakers Perrigo Co. and Actelion Ltd. , in Ireland and Switzerland , may join U.K.-based medical device company Smith & Nephew Plc as acquisition targets for U.S. health-care companies racing to find tax relief abroad before the U.S. government curbs the option.

Comment?

Related Topix: Biotech, Perrigo, Medicine, Actelion, Healthcare Industry, Actelion Pharmaceuticals, Medical Equipment, Shire plc, US Politics, US News, US Senate, Ron Wyden, Democrat

Fri Jul 18, 2014

AmericanBankingNews.com

Smith & Nephew plc (SNN) - Research Analysts' Weekly Ratings Changes

A number of firms have modified their ratings and price targets on shares of Smith & Nephew plc recently: Shares of Smith & Nephew plc opened at 87.88 on Friday.

Comment?

Related Topix: Medical Equipment

Mon Jul 14, 2014

AmericanBankingNews.com

Smith & Nephew plc Receives Consensus Rating of "Buy" from Analysts

Shares of Smith & Nephew plc have earned an average recommendation of "Buy" from the fifteen ratings firms that are covering the company, AnalystRatings.NET reports .

Comment?

Related Topix: Medical Equipment

Fri Jul 11, 2014

AmericanBankingNews.com

Smith & Nephew plc Stock Rating Reaffirmed by Deutsche Bank

's stock had its "buy" rating reiterated by equities researchers at Deutsche Bank in a research report issued on Friday.

Comment?

Related Topix: Medical Equipment, Stanley

Wed Jul 02, 2014

AmericanBankingNews.com

Smith & Nephew plc Given "Outperform" Rating at Sanford C. Bernstein

's stock had its "outperform" rating restated by equities researchers at Sanford C. Bernstein in a research report issued on Wednesday.

Comment?

Related Topix: Medical Equipment, Sanford C. Bernstein

Tue Jun 24, 2014

AmericanBankingNews.com

Smith & Nephew plc Given "Neutral" Rating at Goldman Sachs

's stock had its "neutral" rating restated by equities research analysts at Goldman Sachs in a research note issued to investors on Tuesday.

Comment?

Related Topix: Medical Equipment, Stanley

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••